Medications and wellness products for erectile dysfunction, premature ejaculation, prostate and urinary health, testosterone support, hair-loss treatments, and sexual wellness needs. Includes prescription and over-the-counter options, supplements, and supportive care products.
Medications and wellness products for erectile dysfunction, premature ejaculation, prostate and urinary health, testosterone support, hair-loss treatments, and sexual wellness needs. Includes prescription and over-the-counter options, supplements, and supportive care products.
Men's Health covers a range of prescription and over‑the‑counter medications that address conditions commonly affecting adult males. The category includes treatments for sexual function, hormonal balance, prostate and urinary tract symptoms, and conditions related to male pattern hair loss. Products vary by formulation and purpose, from short‑acting oral tablets to topical gels and fast‑onset sprays or jellies, reflecting the different ways these conditions are managed.
Many treatments in this category are used to relieve symptoms rather than to cure underlying chronic conditions. Erectile dysfunction medicines help achieve or maintain erections for sexual activity, agents for premature ejaculation aim to extend time to ejaculation, and drugs for benign prostatic hyperplasia (BPH) or prostate enlargement reduce urinary frequency, urgency and flow problems. Hormone replacement options are intended to address clinical androgen deficiency, while other medicines are directed at slowing hair loss or managing prostate disease.
Medication types commonly found here include phosphodiesterase type 5 (PDE5) inhibitors for erectile dysfunction, selective serotonin reuptake inhibitors or short‑acting agents for premature ejaculation, alpha‑blockers and 5‑alpha‑reductase inhibitors for prostate and urinary symptoms, topical and injectable testosterone preparations for low androgen states, and antiandrogens used in specific prostate conditions. Examples frequently encountered are sildenafil (widely known as Viagra), tadalafil (Cialis), vardenafil (Levitra) and avanafil (Stendra) among PDE5 inhibitors; dapoxetine (Priligy) for premature ejaculation; finasteride and dutasteride (marketed in formulations such as Propecia, Proscar, Avodart) for hair loss and BPH; topical testosterone products such as AndroGel; and alpha‑blockers like tamsulosin (Flomax) and alfuzosin (Uroxatral).
Formulations vary to meet different needs. Oral tablets remain the most common delivery form for erectile dysfunction and prostate medicines, while some products are available as fast‑acting oral jellies, sublingual sprays, or topical gels for more rapid absorption or localized application. Combination preparations that pair an erectile dysfunction drug with an agent for premature ejaculation also exist, offering a single‑product approach to coexisting issues. Choice of formulation influences onset of action, duration, and convenience for users.
General safety considerations relate to potential side effects, interactions and appropriate indications. Side effects reported with these medicines can include headache, flushing, dizziness, changes in libido, gastrointestinal symptoms, and urinary changes, among others. Certain erectile dysfunction treatments are known to interact with some cardiovascular drugs and may affect blood pressure, and hormonal treatments have systemic effects that require monitoring. Many products are regulated as prescription medicines in many jurisdictions, and authenticity of supply and correct labelling are important for safety.
When comparing options, users typically consider how quickly a product works and how long effects last, route of administration, proven effectiveness, side‑effect profiles and whether a single agent or a combination better matches their needs. Regulatory status, formulation convenience and documented quality are also common priorities. Clear product information about indications, typical effects and formulation helps users make informed choices within this therapeutic area.